What's sending this ASX 300 share 10% higher today?

Shareholders of this company will be smiling on Friday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The APM Human Services International Ltd (ASX: APM) share price is ending the week in style.

In morning trade, the ASX 300 share is up almost 11% to $2.06.

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today.

Image source: Getty Images

Why is this ASX 300 share rocketing higher?

Investors have been scrambling to buy this human services provider's shares today after it announced a major contract win in the UK.

According to the release, APM has been confirmed as the successful bidder to deliver Functional Assessment Services (FAS) on behalf of the Department for Work and Pensions (DWP) in the London, South-East, and East Anglia region.

The release notes that these services provide an assessment of the functional impact of disability and illness on an individual's daily life and their needs as a result of their health conditions.

The contract is for an initial five-year period and has a total value of $720 million or 384 million pounds. It is expected to commence in 2024 and includes an option for a two-year extension.

It is worth noting that this revenue won't all flow through to the bottom line, though. The company will require an investment in capital expenditure and working capital in FY 2023 and FY 2024 before the contract commences.

Speaking of profits, the ASX 300 share has also provided the market with an update on its performance and guidance for FY 2023.

Trading update

Pleasingly, APM continues to make positive progress in executing its strategy. It also continues to increase its average tenure across key programs through new contract awards, retenders, and extensions. This has seen the base tenure (excluding future options) being more than 3 years across its largest contracts.

As for its guidance, the company is expecting its FY 2023 underlying net profit after tax and before amortisation (NPATA) to be in the range of $175 million and $180 million.

This will be up from $166.3 million despite the impacts of lower client flow into Employment Services Programs, a shortage of qualified allied health professionals, and higher interest costs.

Commenting on the contract award, APM Group's CEO, Michael Anghie, said:

We look forward to partnering with the Department of Work and Pensions to deliver these important Functional Assessment Services. APM is one of the leading health service providers in Australia delivering Assessment Services across a wide range of sectors including Health, Disability and Aged Care.

The opportunity to deliver Functional Assessment Services demonstrates the strength of our local service delivery team, our reputation for service excellence, and our ability to leverage APM's expertise across regions and markets. The contract win continues the trend of APM executing its strategy and diversifying its business globally both geographically and in terms of service and revenue models.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended APM Human Services International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Happy man working on his laptop.
Healthcare Shares

This ASX healthcare stock is up 70% in a year and climbing again today

Another strong quarter keeps the Cogstate stock in focus.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX healthcare stock could more than double according to Canaccord Genuity

It's shaping up as a big year for this drug developer.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Healthcare Shares

Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off

Neuren shares jump after DAYBUE STIX expands across the US.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

After a 30% 2026 slide, Pro Medicus shares are rocketing again

Pro Medicus shares jump after another major contract win.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Healthcare Shares

Could the CSL share price reach $200 in 2026?

The biotech's shares have had a tough run, but the long-term story may not be broken.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Pro Medicus announces $23m US contract

Pro Medicus has signed a $23 million, five-year cloud imaging contract with University of Maryland Medical System.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

2 classy ASX healthcare stocks to buy before the next market surge

If sentiment shifts, these global powerhouses could lead the rally.

Read more »